NCT02182193View on ClinicalTrials.gov

Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

BIBF 1120 capsules charge 1

DRUG

BIBF 1120 capsules charge 2

DRUG

BIBF 1120 drinking solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02182193 - Safety and Relative Bioavailability of BIBF 1120 Soft Gelatine Capsules Charge 1, BIBF 1120 Soft Gelatine Capsules Charge 2 and BIBF 1120 Drinking Solution in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter